title: Intrathecal neurokinin-1 receptor antagonist reduces isoflurane MAC in rats.
abstract: OBJECTIVE
  To study the effects of intrathecal administration of a neurokinin-I(NK-I) receptor antagonist (CP96,345) on the minimum alveolar anaesthetic concentration (MAC) of isoflurane in anaesthetized rats, and on the locomotive activity of conscious rats.
  
  
  METHODS
  Wistar rats (n = 36) were fitted with indwelling intrathecal catheters, and the MAC of isoflurane was determined following the intrathecal administration of saline (control group) or the NK-I receptor antagonist CP96,345 (CP) at 1, 10 and 100 micrograms. Subsequently a reversal dose of intrathecal Substance P (SP) at 1, 10 and 100 micrograms was administered and MAC isoflurane was redetermined. Conscious rats (n = 35) were also examined for the presence of locomotor dysfunction following intrathecal administration of CP and SP. Animals were randomly assigned to each treatment group and the investigators were blinded.
  
  
  RESULTS
  CP at 10 and 100 micrograms reduced MAC isoflurane by 9.9% and 15.3%, respectively (P < 0.05). Intrathecal administration of SP reversed the decreases in MAC by CP; however, locomotive activity was not changed.
  
  
  CONCLUSIONS
  These results suggest that the NK-1 receptor plays an important role in determining the MAC of isoflurane by inhibition of pain transmission in the spinal cord.
authors.affiliation: Department of Anesthesiology and Reanimatology, Gunma University School of Medicine, Maebashi, Japan. ishizaki@news.sb.gunma-u.ac.jp
authors.forename: K
authors.initials: K
authors.lastname: Ishizaki
authors.forename: S
authors.initials: S
authors.lastname: Karasawa
authors.forename: K
authors.initials: K
authors.lastname: Takahashi
authors.forename: M
authors.initials: M
authors.lastname: Hasegawa
authors.forename: F
authors.initials: F
authors.lastname: Goto
mesh_terms: D018685:Anesthetics, Inhalation / Q000493:pharmacokinetics*; D000818:Animals; D001713:Biphenyl Compounds / Q000008:administration & dosage*; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D007530:Isoflurane / Q000493:pharmacokinetics*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D064729:Neurokinin-1 Receptor Antagonists; D010146:Pain / Q000517:prevention & control*; D011650:Pulmonary Alveoli / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects
chemical_list: D018685:Anesthetics, Inhalation; D001713:Biphenyl Compounds; D018691:Excitatory Amino Acid Antagonists; D064729:Neurokinin-1 Receptor Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D007530:Isoflurane; C066892:CP 96345